(Q71248587)
Statements
A phase I/II trial of Z-Dex (oral idarubicin and dexamethasone), an oral equivalent of VAD, as initial therapy at diagnosis or progression in multiple myeloma (English)
G Cook
R A Sharp
P Tansey
scientific article published on 01 June 1996